{"id":"https://openalex.org/W2098057508","doi":"https://doi.org/10.1128/aac.01183-09","title":"Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa","display_name":"Clinical Pharmacodynamics of Cefepime in Patients Infected with Pseudomonas aeruginosa","alternate_titles":[],"publication_year":2009,"publication_date":"2009-12-28","ids":{"openalex":"https://openalex.org/W2098057508","doi":"https://doi.org/10.1128/aac.01183-09","mag":"2098057508","pmid":"https://pubmed.ncbi.nlm.nih.gov/20038614","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2825990"},"language":"en","primary_location":{"id":"doi:10.1128/aac.01183-09","doi":"https://doi.org/10.1128/aac.01183-09","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01183-09","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2098057508"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2825990/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089205794","display_name":"Jared L. Crandon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jared L. Crandon","raw_affiliation_strings":["Center for Anti-Infective Research and Development, Hartford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Anti-Infective Research and Development, Hartford, Connecticut","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019354236","display_name":"Catharine C. Bulik","orcid":"https://orcid.org/0009-0003-0015-7083","observed_orcids":["https://orcid.org/0009-0003-0015-7083"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catharine C. Bulik","raw_affiliation_strings":["Center for Anti-Infective Research and Development, Hartford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Anti-Infective Research and Development, Hartford, Connecticut","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090657231","display_name":"Joseph L. Kuti","orcid":"https://orcid.org/0000-0002-4464-3126","observed_orcids":["https://orcid.org/0000-0002-4464-3126"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph L. Kuti","raw_affiliation_strings":["Center for Anti-Infective Research and Development, Hartford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Anti-Infective Research and Development, Hartford, Connecticut","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090740872","display_name":"David P. Nicolau","orcid":"https://orcid.org/0000-0002-4148-0165","observed_orcids":["https://orcid.org/0000-0002-4148-0165"]},"institutions":[{"id":"https://openalex.org/I1302163369","display_name":"Hartford Hospital","ror":"https://ror.org/00gt5xe03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302163369"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David P. Nicolau","raw_affiliation_strings":["Center for Anti-Infective Research and Development, Hartford, Connecticut","Division of Infectious Diseases, Hartford Hospital, Hartford, Connecticut"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Anti-Infective Research and Development, Hartford, Connecticut","institution_ids":[]},{"raw_affiliation_string":"Division of Infectious Diseases, Hartford Hospital, Hartford, Connecticut","institution_ids":["https://openalex.org/I1302163369"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5090740872"],"corresponding_institution_ids":["https://openalex.org/I1302163369"],"apc_list":null,"apc_paid":null,"fwci":4.0571,"has_fulltext":false,"cited_by_count":134,"citation_normalized_percentile":{"value":0.92866962,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"54","issue":"3","first_page":"1111","last_page":"1116"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2726","display_name":"Microbiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cefepime","display_name":"cefepime","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pseudomonas-aeruginosa","display_name":"Pseudomonas aeruginosa","score":0.968999981880188},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8009999990463257},{"id":"https://openalex.org/keywords/microbiological-response","display_name":"microbiological response","score":0.6460000276565552},{"id":"https://openalex.org/keywords/treatment-failure","display_name":"treatment failure","score":0.6690000295639038},{"id":"https://openalex.org/keywords/pneumonia","display_name":"pneumonia","score":0.48899999260902405},{"id":"https://openalex.org/keywords/skin-and-skin-structure-infections","display_name":"skin and skin structure infections","score":0.9950000047683716},{"id":"https://openalex.org/keywords/bacteremia","display_name":"bacteremia","score":0.9950000047683716},{"id":"https://openalex.org/keywords/population-pharmacokinetic-model","display_name":"population pharmacokinetic model","score":0.671999990940094},{"id":"https://openalex.org/keywords/dosing-regimen-optimization","display_name":"dosing regimen optimization","score":0.7720000147819519},{"id":"https://openalex.org/keywords/classification-and-regression-trees","display_name":"classification and regression trees","score":0.6700000166893005},{"id":"https://openalex.org/keywords/monte-carlo-simulation","display_name":"Monte Carlo simulation","score":0.7649999856948853},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.44999998807907104},{"id":"https://openalex.org/keywords/beta-lactam-antibiotics","display_name":"beta-lactam antibiotics","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C2777050379","wikidata":"https://www.wikidata.org/wiki/Q2552927","display_name":"Cefepime","level":5,"score":0.951048731803894},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.8231220245361328},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6420737504959106},{"id":"https://openalex.org/C2777637488","wikidata":"https://www.wikidata.org/wiki/Q31856","display_name":"Pseudomonas aeruginosa","level":3,"score":0.5499493479728699},{"id":"https://openalex.org/C2779443120","wikidata":"https://www.wikidata.org/wiki/Q650912","display_name":"Bacteremia","level":3,"score":0.5219644904136658},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5197065472602844},{"id":"https://openalex.org/C2776968632","wikidata":"https://www.wikidata.org/wiki/Q808845","display_name":"Ceftazidime","level":4,"score":0.5170896053314209},{"id":"https://openalex.org/C81396022","wikidata":"https://www.wikidata.org/wiki/Q489461","display_name":"Etest","level":3,"score":0.4934598505496979},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.452629029750824},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.43928009271621704},{"id":"https://openalex.org/C176947019","wikidata":"https://www.wikidata.org/wiki/Q597889","display_name":"Minimum inhibitory concentration","level":3,"score":0.4119827449321747},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4042556881904602},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3881470859050751},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3602833151817322},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.31383898854255676},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2206745445728302},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077723","descriptor_name":"Cefepime","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009010","descriptor_name":"Monte Carlo Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011550","descriptor_name":"Pseudomonas aeruginosa","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011552","descriptor_name":"Pseudomonas Infections","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.01183-09","doi":"https://doi.org/10.1128/aac.01183-09","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.01183-09","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2825990","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2825990/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:20038614","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20038614","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1000.1886","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1000.1886","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://aac.asm.org/content/54/3/1111.full.pdf","raw_type":"text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2825990","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2825990/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W611976593","https://openalex.org/W1598844438","https://openalex.org/W1998996093","https://openalex.org/W2000445173","https://openalex.org/W2001280008","https://openalex.org/W2057226149","https://openalex.org/W2071637551","https://openalex.org/W2098357010","https://openalex.org/W2106307190","https://openalex.org/W2106729847","https://openalex.org/W2106847523","https://openalex.org/W2113717321","https://openalex.org/W2116352191","https://openalex.org/W2125675160","https://openalex.org/W2126528279","https://openalex.org/W2130793449","https://openalex.org/W2131171455","https://openalex.org/W2131173790","https://openalex.org/W2133979383","https://openalex.org/W2142365884","https://openalex.org/W2147812473","https://openalex.org/W2148790004","https://openalex.org/W2149061072","https://openalex.org/W2157073019","https://openalex.org/W2159416368","https://openalex.org/W2164370556","https://openalex.org/W4211194064","https://openalex.org/W4293242440"],"related_works":["https://openalex.org/W2129085875","https://openalex.org/W2111805706","https://openalex.org/W2166623634","https://openalex.org/W2143718118","https://openalex.org/W2065177826","https://openalex.org/W2674659437","https://openalex.org/W2977252781","https://openalex.org/W2029795370","https://openalex.org/W2060495363"],"abstract_inverted_index":{"We":[0],"evaluated":[1],"cefepime":[2,29,33,167,220,233,368],"exposures":[3,34,186,369],"in":[4,178,350],"patients":[5,147,165,300,351,357],"infected":[6],"with":[7,20,28,148,209,301,352,358],"Pseudomonas":[8],"aeruginosa":[9,24,45,348],"to":[10,85,102,118,134,141,174,191,196,202,281,295,317,322,340],"identify":[11],"the":[12,57,61,67,70,76,79,86,90,93,96,103,120,126,136,143,270,377],"pharmacodynamic":[13,52,121,144],"relationship":[14],"predictive":[15],"of":[16,56,69,78,82,92,125,187,214,250,306,330,367,370,379],"microbiological":[17,127,326,382],"response.":[18,128,327,383],"Patients":[19],"non-urinary":[21,359],"tract":[22,360],"P.":[23,44,347,364],"infections":[25,155,264,361],"and":[26,51,89,112,152,158,184,198,261,286],"treated":[27],"were":[30,35,47,106,161,265,310],"included.":[31,162],"Free":[32],"estimated":[36],"by":[37,49,363],"using":[38],"a":[39,324,380],"validated":[40],"population":[41],"pharmacokinetic":[42],"model.":[43],"MICs":[46,170],"determined":[48],"Etest":[50],"indices":[53],"(the":[54],"percentage":[55],"dosing":[58,138],"interval":[59],"that":[60],"free":[62,83,100],"drug":[63,84,101],"concentration":[64,81],"remains":[65],"above":[66],"MIC":[68,87,104,213,225,238,248,304,374],"infecting":[71],"organism":[72],"[fT":[73],">":[74,181,212,224,237,247,303,373],"MIC],":[75],"ratio":[77,91,274],"minimum":[80],"[fC(min)/MIC],":[88],"area":[94],"under":[95],"concentration-time":[97],"curve":[98],"for":[99,108,123,269],"[fAUC/MIC])":[105],"calculated":[107],"each":[109],"patient.":[110],"Classification":[111],"regression":[113],"tree":[114],"analysis":[115],"was":[116,132,207,226,239,257],"used":[117],"partition":[119],"parameters":[122],"prediction":[124],"Monte":[129],"Carlo":[130],"simulation":[131],"utilized":[133],"determine":[135],"optimal":[137],"regimens":[139],"needed":[140],"achieve":[142,341],"target.":[145],"Fifty-six":[146],"pneumonia":[149],"(66.1%),":[150],"skin":[151,153,260,262],"structure":[154,263],"(SSSIs)":[156],"(25%),":[157],"bacteremia":[159],"(8.9%)":[160],"Twenty-four":[163],"(42.9%)":[164],"failed":[166,219,232],"therapy.":[168],"The":[169],"ranged":[171],"from":[172],"0.75":[173],"96":[175],"microg/ml,":[176],"resulting":[177],"median":[179],"fT":[180,211,223,236,246,302,372],"MIC,":[182],"fC(m)(in)/MIC,":[183],"fAUC/MIC":[185],"100%":[188],"(range,":[189,194,200],"0.8":[190],"100%),":[192],"4.3":[193],"0.1":[195],"27.3),":[197],"206.2":[199],"4.2":[201],"1,028.7),":[203],"respectively.":[204],"Microbiological":[205],"failure":[206],"associated":[208],"an":[210],"<":[215,227,251,307],"or":[216,228,252,308],"=60%":[217,309],"(77.8%":[218],"therapy":[221,234,288],"when":[222,235,259],"=60%,":[229],"whereas":[230],"36.2%":[231],">60%;":[240],"P":[241,283,297],"=":[242,255,284,298],"0.013).":[243],"A":[244],"similar":[245],"target":[249,343],"=63.9%":[253],"(P":[254],"0.009)":[256],"identified":[258],"excluded.":[266],"While":[267],"controlling":[268],"SSSI":[271],"source":[272],"(odds":[273],"[OR],":[275],"0.18":[276],"[95%":[277,291],"confidence":[278,292,314],"interval,":[279,293,315],"0.03":[280],"1.19];":[282],"0.07)":[285],"combination":[287],"(OR,":[289],"2.15":[290],"0.59":[294],"7.88];":[296],"0.25),":[299],"values":[305],"8.1":[311],"times":[312],"(95%":[313],"1.2":[316],"55.6":[318],"times)":[319],"more":[320],"likely":[321],"experience":[323],"poor":[325,381],"Cefepime":[328],"doses":[329],"at":[331],"least":[332],"2":[333],"g":[334],"every":[335],"8":[336],"h":[337],"are":[338],"required":[339],"this":[342],"against":[344],"CLSI-defined":[345],"susceptible":[346],"organisms":[349],"normal":[353],"renal":[354],"function.":[355],"In":[356],"caused":[362],"aeruginosa,":[365],"achievement":[366],">60%":[371],"will":[375],"minimize":[376],"possibility":[378]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2098057508","counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
